SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.;JIANGSU HENGRUI MEDICINE CO., LTD.
发明人:
WU, TINGTING,LI, HAO,LIU, XUN
申请号：
CA3070016
公开号：
CA3070016A1
申请日:
2018.07.24
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
A pharmaceutical composition, which comprises an IL-15 protein complex and a citrate buffer solution. In addition, the pharmaceutical composition may also comprise a sugar and a non-ionic surfactant. The pharmaceutical composition demonstrates a high degree of stability even after being stored at 2-8 °C for several months.
